AstraZeneca
1,649.50 SEK
+0.15 %
Less than 1K followers
AZN
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+0.15 %
-3.17 %
-3.11 %
+6.28 %
+11.23 %
+7.08 %
+21.55 %
+91.82 %
+8,925.74 %
AstraZeneca is a global pharmaceutical company focused on the research, development and marketing of prescription medicines, primarily for the treatment of diseases in the therapeutic areas of respiratory, cardiovascular/metabolic and cancer. In addition to its core business, the company also has a focus on the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in all global regions and is headquartered in Cambridge, UK.
Read moreMarket cap
2.56T SEK
Turnover
301.51M SEK
Revenue
596.39B
EBIT %
18.5 %
P/E
32.94
Dividend yield-%
2.07 %
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
10/2
2026
Annual report '25
29/4
2026
Interim report Q1'26
All
Press releases
ShowingAll content types
AstraZeneca plans to invest $15 billion in China through 2030 to pioneer the next-generation of innovative medicines
AstraZeneca to complete direct listing of ordinary shares and all US debt securities on the New York Stock Exchange
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools